Patents by Inventor Robert W. Watkins

Robert W. Watkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiglaucoma compositions and methods
    Patent number: 5688770
    Abstract: The present invention relates to ophthalmo-logical pharmaceutical compositions comprising a renin inhibitor and to methods for using said composition in the treatment of glaucoma.
    Type: Grant
    Filed: April 7, 1994
    Date of Patent: November 18, 1997
    Assignee: Schering Corporation
    Inventor: Robert W. Watkins
  • Antiglaucoma compositions and methods
    Patent number: 5352666
    Abstract: The present invention relates to ophthalmological pharmaceutical compositions comprising a renin inhibitor and to methods for using said composition in the treatment of glaucoma.
    Type: Grant
    Filed: December 14, 1989
    Date of Patent: October 4, 1994
    Assignee: Schering Corporation
    Inventor: Robert W. Watkins
  • Angiotensin II receptor blockers as antiglaucoma agents
    Patent number: 5182264
    Abstract: A method and composition for reducing and/or controlling elevated intraocular pressure, especially the elevated intraocular pressure associated with glaucoma, are disclosed in which an angiotensin II antagonist is administered to the eye.
    Type: Grant
    Filed: May 6, 1991
    Date of Patent: January 26, 1993
    Assignee: Schering Corporation
    Inventor: Robert W. Watkins
  • Angiotensin II receptor blockers as antiglaucoma agents
    Patent number: 5036048
    Abstract: A method and composition for reducing and/or controlling elevated intraocular pressure, especially the elevated intraocular pressure associated with glaucoma, are disclosed in which an angiotensin II antagonist is administered to the eye.
    Type: Grant
    Filed: March 7, 1986
    Date of Patent: July 30, 1991
    Assignee: Schering Corporation
    Inventor: Robert W. Watkins
  • Carboxyalkyl dipeptides as antiglaucoma agents
    Patent number: 5017567
    Abstract: Methods and pharmaceutical compositions are disclosed for reducing intraocular pressure. The methods and compositions employ an active ingredient which comprises certain benzothiadiazinyl and quinazolinyl substituted carboxyalkyl dipeptides wherein the benzothiadiazinyl or quinazolinyl portions are joined to the dipeptide portions by an aminocarbonyl group.
    Type: Grant
    Filed: January 3, 1990
    Date of Patent: May 21, 1991
    Assignee: Schering Corporation
    Inventors: Bernard R. Neustadt, David R. Andrews, Paul E. McNamara, Robert W. Watkins
  • Antiglaucoma agents
    Patent number: 5015641
    Abstract: Pharmaceutical compositions and a method for reducing intraocular pressure by topically applying a carboxyalkyl dipeptide are disclosed.
    Type: Grant
    Filed: May 9, 1989
    Date of Patent: May 14, 1991
    Inventors: David R. Andrews, Federico C. A. Gaeta, Robert W. Watkins
  • Ophthalmic compositions
    Patent number: 4914090
    Abstract: The use of an angiotensin converting enzyme inhibitor for reducing and controlling the elevation of intraocular pressure associated with the use of corticosteroids is disclosed. Also disclosed are the use of the combination of an angiotensin converting enzyme inhibitor and a steroid, and pharmaceutical compositions comprising the combination.
    Type: Grant
    Filed: November 1, 1985
    Date of Patent: April 3, 1990
    Assignee: Schering Corporation
    Inventor: Robert W. Watkins
  • Carboxyalkyl dipeptides as antiglaucoma agents
    Patent number: 4906635
    Abstract: Methods and pharmaceutical compositions are disclosed for reducing intraocular pressure. The methods and compositions employ an active ingredient which comprises certain benzothiadiazinyl and quinazolinyl substituted carboxyalkyl dipeptides wherein the benzothiadiazinyl or quinazolinyl portions are joined to the dipeptide portions by an aminocarbonyl group.
    Type: Grant
    Filed: July 18, 1988
    Date of Patent: March 6, 1990
    Assignee: Schering Corporation
    Inventors: Bernard R. Neustadt, David R. Andrews, Paul E. McNamara, Robert W. Watkins
  • Antiglaucoma compositions and methods
    Patent number: 4906613
    Abstract: The present invention relates to ophthalmological pharmaceutical compositions comprising a renin inhibitor and to methods for using said composition in the treatment of glaucoma.
    Type: Grant
    Filed: November 5, 1985
    Date of Patent: March 6, 1990
    Assignee: Schering Corporation
    Inventor: Robert W. Watkins
  • Antiglaucoma agents
    Patent number: 4885293
    Abstract: Pharmaceutical compositions and a method for reducing intraocular pressure by topically applying a carboxyalkyl dipeptide are disclosed.
    Type: Grant
    Filed: July 30, 1986
    Date of Patent: December 5, 1989
    Assignee: Schering Corporation
    Inventors: David R. Andrews, Federico C. A. Gaeta, Robert W. Watkins
  • Antiglaucoma agent
    Patent number: 4826812
    Abstract: A method for reducing intraocular pressure by topically applying 7-{N-[1(S)-Carboxy-3-phenylpropyl]-(S)-alanyl}-1,4-dithia-7-azaspiro[4.4]n onane-8(S)-carboxylic acid is disclosed.
    Type: Grant
    Filed: July 23, 1986
    Date of Patent: May 2, 1989
    Assignee: Schering Corporation
    Inventor: Robert W. Watkins
  • Carboxyalkyl dipeptides as antiglaucoma agents
    Patent number: 4778795
    Abstract: Methods and pharmaceutical compositions are disclosed for reducing intraocular pressure. The methods and compositions employ an active ingredient which comprises certain benzothiadiazinyl and quinazolinyl substituted carboxyalkyl dipeptides wherein the benzothiadiazinyl or quinazolinyl portions are joined to the dipeptide portions by an aminocarbonyl group.
    Type: Grant
    Filed: September 3, 1986
    Date of Patent: October 18, 1988
    Assignee: Schering Corporation
    Inventors: Bernard R. Neustadt, David R. Andrews, Paul E. McNamara, Robert W. Watkins
  • Tricyclic positive inotropic agents
    Patent number: 4680297
    Abstract: Substituted quinoline, [1,5]- and [1,8]-naphthyridine and pyrido [2,3-b]pyrazine derivatives are useful positive inotropic agents.
    Type: Grant
    Filed: June 20, 1985
    Date of Patent: July 14, 1987
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Robert W. Watkins
  • Carboxyalkyl dipeptides as antiglaucoma agents
    Patent number: 4616012
    Abstract: Methods and pharmaceutical compositions are disclosed for reducing intraocular pressure. The methods and compositions employ an active ingredient which comprises certain benzothiadiazinyl and quinazolinyl substituted carboxyalkyl dipeptides wherein the benzothiadiazinyl or quinazolinyl portions are joined to the dipeptide portions by an aminocarbonyl group.
    Type: Grant
    Filed: November 12, 1985
    Date of Patent: October 7, 1986
    Assignee: Schering Corporation
    Inventors: Bernard R. Neustadt, David R. Andrews, Paul E. McNamara, Robert W. Watkins